Seminar on preclinical imaging planned for December

Carestream Molecular Imaging is sponsoring a complimentary seminar on Imaging Technologies & Strategies in Pre-Clinical Small Animal Research on Dec. 6, in Cambridge, Mass.

In this half-day seminar, participants will explore the work of three independent research scientists from Harvard University in Cambridge, Mass., Baylor University in Waco, Texas, and Thomas Jefferson University in Philadelphia, who specialize in small animal research using optical/x-ray, nuclear and/or CT systems.

They will discuss the role of using diverse imaging modalities within their research, including fusion techniques and strategies, to simultaneously study biodistribution and efficacy of therapeutic candidates, new probe development and validation, as well as designing target-specific theragnostics and monitoring therapeutic efficacy.

There will also be a presentation by scientists from Carestream on new PET and SPECT detector technologies, as well as a discussion regarding a new platform architecture for high resolution optical/x-ray imaging that combines luminescence, fluorescence, radioisotopic and x-ray modalities in one system.

In vivo imaging topics to be covered:
  • Biomarker development and validation;
  • Therapeutics delivery and efficacy evaluation;
  • Oncology and infectious disease model progression assessment;
  • Protein expression and receptor occupancy studies; and
  • A review of multimodal imaging studies from peer-reviewed literature.

The seminar will take place at the Boston Marriott Cambridge from 8:30am to 2:00pm.

For more information, and to register, click here.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup